"Protection Conferred by Recombinant VSV–Based Vaccines Against Filoviruses

December 1, 12:00pm - 1:00pm
Honolulu Campus, JABSOM Medical Education Building Room 301

Ebola virus (EBOV) causes a severe and often fatal hemorrhagic fever in humans and nonhuman primates. The 2014-2016 EBOV epidemic resulted in 28,616 cases and 11,310 fatalities. This tragedy spurred the development of vaccines against this devastating disease. In this seminar, we will discuss mechanisms of EBOV pathogenesis as well as correlates of protection mediated by the recombinant vesicular stomatitis virus expressing EBOV glycoprotein which has advanced to phase 2/3 clinical trials.

Event Sponsor
American Society of Microbiology Hawaii Chapter & Student Immunization Initiative, Honolulu Campus

More Information
Joanna Kettlewell, (804) 370-6123, jmkettle@hawaii.edu, http://443 Kuamoo St, Enter Title Here (PDF)

Share by email